APO Research
Talk to an analyst

APO RESEARCH · REPORT

Medicated Adhesive Patch

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Medicated Adhesive Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025191 pages

Choose your research edition.

Industry ResearchMedicated Adhesive Patch Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Medicated Adhesive Patch Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Medicated Adhesive Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medicated Adhesive Patch Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Medicated Adhesive Patch Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Medicated Adhesive Patch market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Medicated Adhesive Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medicated Adhesive Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medicated Adhesive Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Medicated Adhesive Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Medicated Adhesive Patch include Johnson & Johnson, Novartis, Mylan, Pfizer, GSK, Beijing Tide Pharmaceutical, Bayer, UCB Pharma and Teva Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Medicated Adhesive Patch output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Medicated Adhesive Patch by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Medicated Adhesive Patch market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medicated Adhesive Patch and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medicated Adhesive Patch sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medicated Adhesive Patch market size, projected growth trends, production technologies, key applications, and end-use industries.

Medicated Adhesive Patch Segment by Company

Johnson & Johnson

Novartis

Mylan

Pfizer

GSK

Beijing Tide Pharmaceutical

Bayer

UCB Pharma

Teva Pharmaceutical

Nitto Denko

Mundipharma

Luye Pharma Group

IBSA Group

Hisamitsu Pharmaceutical

Grünenthal

Endo International

Dr Reddy’s Laboratories

Chattem

Medicated Adhesive Patch Segment by Type

Methyl Salicylate-based Patch

Nicotine Transdermal Patch

Rivastigmine Transdermal Patch

Clonidine Transdermal Patch

Fentanyl Transdermal Patch

Oxybutynin Transdermal Patch

Others

Medicated Adhesive Patch Segment by Application

Used to Treat High Blood Pressure

Used to Treat an Overactive Bladder

Used to Relieve Severe Pain

Used to Stop Smoking Cigarettes

Others

Medicated Adhesive Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medicated Adhesive Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medicated Adhesive Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medicated Adhesive Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medicated Adhesive Patch market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medicated Adhesive Patch industry.

Chapter 3: Detailed analysis of Medicated Adhesive Patch market competition landscape. Including Medicated Adhesive Patch manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Medicated Adhesive Patch by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Medicated Adhesive Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Medicated Adhesive Patch Industry Trends Table 2. Medicated Adhesive Patch Industry Drivers Table 3. Medicated Adhesive Patch Industry Opportunities and Challenges Table 4. Medicated Adhesive Patch Industry Restraints Table 5. Global Medicated Adhesive Patch Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Medicated Adhesive Patch Production Value Share by Manufacturers (2021-2026) Table 7. Global Medicated Adhesive Patch Production by Manufacturers (K Units) & (2021-2026) Table 8. Global Medicated Adhesive Patch Production Market Share by Manufacturers Table 9. Global Medicated Adhesive Patch Average Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Medicated Adhesive Patch Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Medicated Adhesive Patch Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Medicated Adhesive Patch Manufacturers, Product Type & Application Table 13. Global Medicated Adhesive Patch Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Medicated Adhesive Patch by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Methyl Salicylate-based Patch Table 17. Major Manufacturers of Nicotine Transdermal Patch Table 18. Major Manufacturers of Rivastigmine Transdermal Patch Table 19. Major Manufacturers of Clonidine Transdermal Patch Table 20. Major Manufacturers of Fentanyl Transdermal Patch Table 21. Major Manufacturers of Oxybutynin Transdermal Patch Table 22. Major Manufacturers of Others Table 23. Global Medicated Adhesive Patch Production by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Medicated Adhesive Patch Production by Type (2021-2026) & (K Units) Table 25. Global Medicated Adhesive Patch Production by Type (2027-2032) & (K Units) Table 26. Global Medicated Adhesive Patch Production Market Share by Type (2021-2026) Table 27. Global Medicated Adhesive Patch Production Market Share by Type (2027-2032) Table 28. Global Medicated Adhesive Patch Production Value by Type 2021 VS 2025 VS 2032 (K Units) Table 29. Global Medicated Adhesive Patch Production Value by Type (2021-2026) & (K Units) Table 30. Global Medicated Adhesive Patch Production Value by Type (2027-2032) & (K Units) Table 31. Global Medicated Adhesive Patch Production Value Market Share by Type (2021-2026) Table 32. Global Medicated Adhesive Patch Production Value Market Share by Type (2027-2032) Table 33. Major Manufacturers of Used to Treat High Blood Pressure Table 34. Major Manufacturers of Used to Treat an Overactive Bladder Table 35. Major Manufacturers of Used to Relieve Severe Pain Table 36. Major Manufacturers of Used to Stop Smoking Cigarettes Table 37. Major Manufacturers of Others Table 38. Global Medicated Adhesive Patch Production by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Medicated Adhesive Patch Production by Application (2021-2026) & (K Units) Table 40. Global Medicated Adhesive Patch Production by Application (2027-2032) & (K Units) Table 41. Global Medicated Adhesive Patch Production Market Share by Application (2021-2026) Table 42. Global Medicated Adhesive Patch Production Market Share by Application (2027-2032) Table 43. Global Medicated Adhesive Patch Production Value by Application 2021 VS 2025 VS 2032 (K Units) Table 44. Global Medicated Adhesive Patch Production Value by Application (2021-2026) & (K Units) Table 45. Global Medicated Adhesive Patch Production Value by Application (2027-2032) & (K Units) Table 46. Global Medicated Adhesive Patch Production Value Market Share by Application (2021-2026) Table 47. Global Medicated Adhesive Patch Production Value Market Share by Application (2027-2032) Table 48. Johnson & Johnson Company Information Table 49. Johnson & Johnson Business Overview Table 50. Johnson & Johnson Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Johnson & Johnson Medicated Adhesive Patch Product Portfolio Table 52. Johnson & Johnson Recent Development Table 53. Novartis Company Information Table 54. Novartis Business Overview Table 55. Novartis Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Novartis Medicated Adhesive Patch Product Portfolio Table 57. Novartis Recent Development Table 58. Mylan Company Information Table 59. Mylan Business Overview Table 60. Mylan Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Mylan Medicated Adhesive Patch Product Portfolio Table 62. Mylan Recent Development Table 63. Pfizer Company Information Table 64. Pfizer Business Overview Table 65. Pfizer Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Pfizer Medicated Adhesive Patch Product Portfolio Table 67. Pfizer Recent Development Table 68. GSK Company Information Table 69. GSK Business Overview Table 70. GSK Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. GSK Medicated Adhesive Patch Product Portfolio Table 72. GSK Recent Development Table 73. Beijing Tide Pharmaceutical Company Information Table 74. Beijing Tide Pharmaceutical Business Overview Table 75. Beijing Tide Pharmaceutical Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Beijing Tide Pharmaceutical Medicated Adhesive Patch Product Portfolio Table 77. Beijing Tide Pharmaceutical Recent Development Table 78. Bayer Company Information Table 79. Bayer Business Overview Table 80. Bayer Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Bayer Medicated Adhesive Patch Product Portfolio Table 82. Bayer Recent Development Table 83. UCB Pharma Company Information Table 84. UCB Pharma Business Overview Table 85. UCB Pharma Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. UCB Pharma Medicated Adhesive Patch Product Portfolio Table 87. UCB Pharma Recent Development Table 88. Teva Pharmaceutical Company Information Table 89. Teva Pharmaceutical Business Overview Table 90. Teva Pharmaceutical Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Teva Pharmaceutical Medicated Adhesive Patch Product Portfolio Table 92. Teva Pharmaceutical Recent Development Table 93. Nitto Denko Company Information Table 94. Nitto Denko Business Overview Table 95. Nitto Denko Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Nitto Denko Medicated Adhesive Patch Product Portfolio Table 97. Nitto Denko Recent Development Table 98. Mundipharma Company Information Table 99. Mundipharma Business Overview Table 100. Mundipharma Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Mundipharma Medicated Adhesive Patch Product Portfolio Table 102. Mundipharma Recent Development Table 103. Luye Pharma Group Company Information Table 104. Luye Pharma Group Business Overview Table 105. Luye Pharma Group Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Luye Pharma Group Medicated Adhesive Patch Product Portfolio Table 107. Luye Pharma Group Recent Development Table 108. IBSA Group Company Information Table 109. IBSA Group Business Overview Table 110. IBSA Group Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. IBSA Group Medicated Adhesive Patch Product Portfolio Table 112. IBSA Group Recent Development Table 113. Hisamitsu Pharmaceutical Company Information Table 114. Hisamitsu Pharmaceutical Business Overview Table 115. Hisamitsu Pharmaceutical Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Hisamitsu Pharmaceutical Medicated Adhesive Patch Product Portfolio Table 117. Hisamitsu Pharmaceutical Recent Development Table 118. Grünenthal Company Information Table 119. Grünenthal Business Overview Table 120. Grünenthal Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Grünenthal Medicated Adhesive Patch Product Portfolio Table 122. Grünenthal Recent Development Table 123. Endo International Company Information Table 124. Endo International Business Overview Table 125. Endo International Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Endo International Medicated Adhesive Patch Product Portfolio Table 127. Endo International Recent Development Table 128. Dr Reddy’s Laboratories Company Information Table 129. Dr Reddy’s Laboratories Business Overview Table 130. Dr Reddy’s Laboratories Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Dr Reddy’s Laboratories Medicated Adhesive Patch Product Portfolio Table 132. Dr Reddy’s Laboratories Recent Development Table 133. Chattem Company Information Table 134. Chattem Business Overview Table 135. Chattem Medicated Adhesive Patch Production (K Units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Chattem Medicated Adhesive Patch Product Portfolio Table 137. Chattem Recent Development Table 138. Global Medicated Adhesive Patch Production by Region: 2021 VS 2025 VS 2032 (K Units) Table 139. Global Medicated Adhesive Patch Production by Region (2021-2026) & (K Units) Table 140. Global Medicated Adhesive Patch Production Market Share by Region (2021-2026) Table 141. Global Medicated Adhesive Patch Production Forecast by Region (2027-2032) & (K Units) Table 142. Global Medicated Adhesive Patch Production Market Share Forecast by Region (2027-2032) Table 143. Global Medicated Adhesive Patch Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 144. Global Medicated Adhesive Patch Production Value by Region (2021-2026) & (US$ Million) Table 145. Global Medicated Adhesive Patch Production Value Share by Region (2021-2026) Table 146. Global Medicated Adhesive Patch Production Value by Region (2027-2032) & (US$ Million) Table 147. Global Medicated Adhesive Patch Production Value Share by Region: (2027-2032) & (US$ Million) Table 148. Global Medicated Adhesive Patch Market Average Price (US$/unit) by Region (2021-2026) Table 149. Global Medicated Adhesive Patch Market Average Price (US$/unit) by Region (2027-2032) Table 150. Global Medicated Adhesive Patch Consumption by Region: 2021 VS 2025 VS 2032 (K Units) Table 151. Global Medicated Adhesive Patch Consumption by Region (2021-2026) & (K Units) Table 152. Global Medicated Adhesive Patch Consumption Market Share by Region (2021-2026) Table 153. Global Medicated Adhesive Patch Consumption Forecasted by Region (2027-2032) & (K Units) Table 154. Global Medicated Adhesive Patch Consumption Forecasted Market Share by Region (2027-2032) Table 155. North America Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 156. North America Medicated Adhesive Patch Consumption by Country (2021-2026) & (K Units) Table 157. North America Medicated Adhesive Patch Consumption by Country (2027-2032) & (K Units) Table 158. Europe Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 159. Europe Medicated Adhesive Patch Consumption by Country (2021-2026) & (K Units) Table 160. Europe Medicated Adhesive Patch Consumption by Country (2027-2032) & (K Units) Table 161. Asia Pacific Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 162. Asia Pacific Medicated Adhesive Patch Consumption by Country (2021-2026) & (K Units) Table 163. Asia Pacific Medicated Adhesive Patch Consumption by Country (2027-2032) & (K Units) Table 164. South America Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 165. South America Medicated Adhesive Patch Consumption by Country (2021-2026) & (K Units) Table 166. South America Medicated Adhesive Patch Consumption by Country (2027-2032) & (K Units) Table 167. Middle East & Africa Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 168. Middle East & Africa Medicated Adhesive Patch Consumption by Country (2021-2026) & (K Units) Table 169. Middle East & Africa Medicated Adhesive Patch Consumption by Country (2027-2032) & (K Units) Table 170. Key Raw Materials Table 171. Raw Materials Key Suppliers Table 172. Medicated Adhesive Patch Distributors List Table 173. Medicated Adhesive Patch Customers List Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Medicated Adhesive Patch Product Image Figure 2. Global Medicated Adhesive Patch Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medicated Adhesive Patch Production Value (2021-2032) & (US$ Million) Figure 4. Global Medicated Adhesive Patch Production Capacity (2021-2032) & (K Units) Figure 5. Global Medicated Adhesive Patch Production (2021-2032) & (K Units) Figure 6. Global Medicated Adhesive Patch Average Price (US$/unit) & (2021-2032) Figure 7. Global Top 5 and 10 Medicated Adhesive Patch Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Methyl Salicylate-based Patch Image Figure 10. Nicotine Transdermal Patch Image Figure 11. Rivastigmine Transdermal Patch Image Figure 12. Clonidine Transdermal Patch Image Figure 13. Fentanyl Transdermal Patch Image Figure 14. Oxybutynin Transdermal Patch Image Figure 15. Others Image Figure 16. Global Medicated Adhesive Patch Production by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Medicated Adhesive Patch Production Market Share 2021 VS 2025 VS 2032 Figure 18. Global Medicated Adhesive Patch Production Market Share by Type (2021-2032) Figure 19. Global Medicated Adhesive Patch Production Value by Type (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Medicated Adhesive Patch Production Value Share 2021 VS 2025 VS 2032 Figure 21. Global Medicated Adhesive Patch Production Value Share by Type (2021-2032) Figure 22. Used to Treat High Blood Pressure Image Figure 23. Used to Treat an Overactive Bladder Image Figure 24. Used to Relieve Severe Pain Image Figure 25. Used to Stop Smoking Cigarettes Image Figure 26. Others Image Figure 27. Global Medicated Adhesive Patch Production by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Medicated Adhesive Patch Production Market Share 2021 VS 2025 VS 2032 Figure 29. Global Medicated Adhesive Patch Production Market Share by Application (2021-2032) Figure 30. Global Medicated Adhesive Patch Production Value by Application (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Medicated Adhesive Patch Production Value Share 2021 VS 2025 VS 2032 Figure 32. Global Medicated Adhesive Patch Production Value Share by Application (2021-2032) Figure 33. Global Medicated Adhesive Patch Production by Region: 2021 VS 2025 VS 2032 (K Units) Figure 34. Global Medicated Adhesive Patch Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 35. Global Medicated Adhesive Patch Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 36. Global Medicated Adhesive Patch Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 37. North America Medicated Adhesive Patch Production Value (2021-2032) & (US$ Million) Figure 38. Europe Medicated Adhesive Patch Production Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Medicated Adhesive Patch Production Value (2021-2032) & (US$ Million) Figure 40. South America Medicated Adhesive Patch Production Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Medicated Adhesive Patch Production Value (2021-2032) & (US$ Million) Figure 42. North America Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 43. North America Medicated Adhesive Patch Consumption Market Share by Country (2021-2032) Figure 44. U.S. Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 45. Canada Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 46. Mexico Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 47. Europe Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 48. Europe Medicated Adhesive Patch Consumption Market Share by Country (2021-2032) Figure 49. Germany Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 50. France Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 51. U.K. Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 52. Italy Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 53. Netherlands Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 54. Asia Pacific Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 55. Asia Pacific Medicated Adhesive Patch Consumption Market Share by Country (2021-2032) Figure 56. China Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 57. Japan Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 58. South Korea Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 59. Southeast Asia Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 60. India Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 61. Australia Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 62. South America Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 63. South America Medicated Adhesive Patch Consumption Market Share by Country (2021-2032) Figure 64. Brazil Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 65. Argentina Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 66. Chile Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 67. Colombia Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 68. Middle East & Africa Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 69. Middle East & Africa Medicated Adhesive Patch Consumption Market Share by Country (2021-2032) Figure 70. Egypt Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 71. South Africa Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 72. Israel Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 73. Türkiye Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 74. GCC Countries Medicated Adhesive Patch Consumption and Growth Rate (2021-2032) & (K Units) Figure 75. Medicated Adhesive Patch Value Chain Figure 76. Manufacturing Cost Structure Figure 77. Medicated Adhesive Patch Production Mode & Process Figure 78. Direct Comparison with Distribution Share Figure 79. Distributors Profiles Figure 80. Years Considered Figure 81. Research Process Figure 82. Key Executives Interviewed

Scope & coverage.

Types
  • Methyl Salicylate-based Patch
  • Nicotine Transdermal Patch
  • Rivastigmine Transdermal Patch
  • Clonidine Transdermal Patch
  • Fentanyl Transdermal Patch
  • Oxybutynin Transdermal Patch
  • Others
Applications
  • Used to Treat High Blood Pressure
  • Used to Treat an Overactive Bladder
  • Used to Relieve Severe Pain
  • Used to Stop Smoking Cigarettes
  • Others
Companies covered
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Pfizer
  • GSK
  • Beijing Tide Pharmaceutical
  • Bayer
  • UCB Pharma
  • Teva Pharmaceutical
  • Nitto Denko
  • Mundipharma
  • Luye Pharma Group
  • IBSA Group
  • Hisamitsu Pharmaceutical
  • Grünenthal
  • Endo International
  • Dr Reddy’s Laboratories
  • Chattem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medicated Adhesive Patch Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Medicated Adhesive Patch Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Medicated Adhesive Patch Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Medicated Adhesive Patch Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Medicated Adhesive Patch Market Dynamics
  1. 2.1 Medicated Adhesive Patch Industry Trends
  2. 2.2 Medicated Adhesive Patch Industry Drivers
  3. 2.3 Medicated Adhesive Patch Industry Opportunities and Challenges
  4. 2.4 Medicated Adhesive Patch Industry Restraints
3 Medicated Adhesive Patch Market by Manufacturers
  1. 3.1 Global Medicated Adhesive Patch Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Medicated Adhesive Patch Production by Manufacturers (2021-2026)
  3. 3.3 Global Medicated Adhesive Patch Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Medicated Adhesive Patch Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Medicated Adhesive Patch Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Medicated Adhesive Patch Manufacturers, Product Type & Application
  7. 3.7 Global Medicated Adhesive Patch Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Medicated Adhesive Patch Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Medicated Adhesive Patch Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Medicated Adhesive Patch Tier 1, Tier 2, and Tier 3
4 Medicated Adhesive Patch Market by Type
  1. 4.1 Medicated Adhesive Patch Type Introduction
  2. 4.1.1 Methyl Salicylate-based Patch
  3. 4.1.2 Nicotine Transdermal Patch
  4. 4.1.3 Rivastigmine Transdermal Patch
  5. 4.1.4 Clonidine Transdermal Patch
  6. 4.1.5 Fentanyl Transdermal Patch
  7. 4.1.6 Oxybutynin Transdermal Patch
  8. 4.1.7 Others
  9. 4.2 Global Medicated Adhesive Patch Production by Type
  10. 4.2.1 Global Medicated Adhesive Patch Production by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Medicated Adhesive Patch Production by Type (2021-2032)
  12. 4.2.3 Global Medicated Adhesive Patch Production Market Share by Type (2021-2032)
  13. 4.3 Global Medicated Adhesive Patch Production Value by Type
  14. 4.3.1 Global Medicated Adhesive Patch Production Value by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Medicated Adhesive Patch Production Value by Type (2021-2032)
  16. 4.3.3 Global Medicated Adhesive Patch Production Value Market Share by Type (2021-2032)
5 Medicated Adhesive Patch Market by Application
  1. 5.1 Medicated Adhesive Patch Application Introduction
  2. 5.1.1 Used to Treat High Blood Pressure
  3. 5.1.2 Used to Treat an Overactive Bladder
  4. 5.1.3 Used to Relieve Severe Pain
  5. 5.1.4 Used to Stop Smoking Cigarettes
  6. 5.1.5 Others
  7. 5.2 Global Medicated Adhesive Patch Production by Application
  8. 5.2.1 Global Medicated Adhesive Patch Production by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Medicated Adhesive Patch Production by Application (2021-2032)
  10. 5.2.3 Global Medicated Adhesive Patch Production Market Share by Application (2021-2032)
  11. 5.3 Global Medicated Adhesive Patch Production Value by Application
  12. 5.3.1 Global Medicated Adhesive Patch Production Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Medicated Adhesive Patch Production Value by Application (2021-2032)
  14. 5.3.3 Global Medicated Adhesive Patch Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Johnson & Johnson
  2. 6.1.1 Johnson & Johnson Company Information
  3. 6.1.2 Johnson & Johnson Business Overview
  4. 6.1.3 Johnson & Johnson Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Johnson & Johnson Medicated Adhesive Patch Product Portfolio
  6. 6.1.5 Johnson & Johnson Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Medicated Adhesive Patch Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Medicated Adhesive Patch Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Medicated Adhesive Patch Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 GSK
  26. 6.5.1 GSK Company Information
  27. 6.5.2 GSK Business Overview
  28. 6.5.3 GSK Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 GSK Medicated Adhesive Patch Product Portfolio
  30. 6.5.5 GSK Recent Developments
  31. 6.6 Beijing Tide Pharmaceutical
  32. 6.6.1 Beijing Tide Pharmaceutical Company Information
  33. 6.6.2 Beijing Tide Pharmaceutical Business Overview
  34. 6.6.3 Beijing Tide Pharmaceutical Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Beijing Tide Pharmaceutical Medicated Adhesive Patch Product Portfolio
  36. 6.6.5 Beijing Tide Pharmaceutical Recent Developments
  37. 6.7 Bayer
  38. 6.7.1 Bayer Company Information
  39. 6.7.2 Bayer Business Overview
  40. 6.7.3 Bayer Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Bayer Medicated Adhesive Patch Product Portfolio
  42. 6.7.5 Bayer Recent Developments
  43. 6.8 UCB Pharma
  44. 6.8.1 UCB Pharma Company Information
  45. 6.8.2 UCB Pharma Business Overview
  46. 6.8.3 UCB Pharma Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 UCB Pharma Medicated Adhesive Patch Product Portfolio
  48. 6.8.5 UCB Pharma Recent Developments
  49. 6.9 Teva Pharmaceutical
  50. 6.9.1 Teva Pharmaceutical Company Information
  51. 6.9.2 Teva Pharmaceutical Business Overview
  52. 6.9.3 Teva Pharmaceutical Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Teva Pharmaceutical Medicated Adhesive Patch Product Portfolio
  54. 6.9.5 Teva Pharmaceutical Recent Developments
  55. 6.10 Nitto Denko
  56. 6.10.1 Nitto Denko Company Information
  57. 6.10.2 Nitto Denko Business Overview
  58. 6.10.3 Nitto Denko Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Nitto Denko Medicated Adhesive Patch Product Portfolio
  60. 6.10.5 Nitto Denko Recent Developments
  61. 6.11 Mundipharma
  62. 6.11.1 Mundipharma Company Information
  63. 6.11.2 Mundipharma Business Overview
  64. 6.11.3 Mundipharma Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  65. 6.11.4 Mundipharma Medicated Adhesive Patch Product Portfolio
  66. 6.11.5 Mundipharma Recent Developments
  67. 6.12 Luye Pharma Group
  68. 6.12.1 Luye Pharma Group Company Information
  69. 6.12.2 Luye Pharma Group Business Overview
  70. 6.12.3 Luye Pharma Group Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  71. 6.12.4 Luye Pharma Group Medicated Adhesive Patch Product Portfolio
  72. 6.12.5 Luye Pharma Group Recent Developments
  73. 6.13 IBSA Group
  74. 6.13.1 IBSA Group Company Information
  75. 6.13.2 IBSA Group Business Overview
  76. 6.13.3 IBSA Group Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  77. 6.13.4 IBSA Group Medicated Adhesive Patch Product Portfolio
  78. 6.13.5 IBSA Group Recent Developments
  79. 6.14 Hisamitsu Pharmaceutical
  80. 6.14.1 Hisamitsu Pharmaceutical Company Information
  81. 6.14.2 Hisamitsu Pharmaceutical Business Overview
  82. 6.14.3 Hisamitsu Pharmaceutical Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  83. 6.14.4 Hisamitsu Pharmaceutical Medicated Adhesive Patch Product Portfolio
  84. 6.14.5 Hisamitsu Pharmaceutical Recent Developments
  85. 6.15 Grünenthal
  86. 6.15.1 Grünenthal Company Information
  87. 6.15.2 Grünenthal Business Overview
  88. 6.15.3 Grünenthal Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  89. 6.15.4 Grünenthal Medicated Adhesive Patch Product Portfolio
  90. 6.15.5 Grünenthal Recent Developments
  91. 6.16 Endo International
  92. 6.16.1 Endo International Company Information
  93. 6.16.2 Endo International Business Overview
  94. 6.16.3 Endo International Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  95. 6.16.4 Endo International Medicated Adhesive Patch Product Portfolio
  96. 6.16.5 Endo International Recent Developments
  97. 6.17 Dr Reddy’s Laboratories
  98. 6.17.1 Dr Reddy’s Laboratories Company Information
  99. 6.17.2 Dr Reddy’s Laboratories Business Overview
  100. 6.17.3 Dr Reddy’s Laboratories Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  101. 6.17.4 Dr Reddy’s Laboratories Medicated Adhesive Patch Product Portfolio
  102. 6.17.5 Dr Reddy’s Laboratories Recent Developments
  103. 6.18 Chattem
  104. 6.18.1 Chattem Company Information
  105. 6.18.2 Chattem Business Overview
  106. 6.18.3 Chattem Medicated Adhesive Patch Production, Value and Gross Margin (2021-2026)
  107. 6.18.4 Chattem Medicated Adhesive Patch Product Portfolio
  108. 6.18.5 Chattem Recent Developments
7 Global Medicated Adhesive Patch Production by Region
  1. 7.1 Global Medicated Adhesive Patch Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Medicated Adhesive Patch Production by Region (2021-2032)
  3. 7.2.1 Global Medicated Adhesive Patch Production by Region (2021-2026)
  4. 7.2.2 Global Medicated Adhesive Patch Production Forecast by Region (2027-2032)
  5. 7.3 Global Medicated Adhesive Patch Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Medicated Adhesive Patch Production Value by Region (2021-2032)
  7. 7.4.1 Global Medicated Adhesive Patch Production Value by Region (2021-2026)
  8. 7.4.2 Global Medicated Adhesive Patch Production Value by Region (2027-2032)
  9. 7.5 Global Medicated Adhesive Patch Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Medicated Adhesive Patch Production Value (2021-2032)
  12. 7.6.2 Europe Medicated Adhesive Patch Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Medicated Adhesive Patch Production Value (2021-2032)
  14. 7.6.4 South America Medicated Adhesive Patch Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Medicated Adhesive Patch Production Value (2021-2032)
8 Global Medicated Adhesive Patch Consumption by Region
  1. 8.1 Global Medicated Adhesive Patch Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Medicated Adhesive Patch Consumption by Region (2021-2032)
  3. 8.2.1 Global Medicated Adhesive Patch Consumption by Region (2021-2026)
  4. 8.2.2 Global Medicated Adhesive Patch Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Medicated Adhesive Patch Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Medicated Adhesive Patch Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Medicated Adhesive Patch Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Medicated Adhesive Patch Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Medicated Adhesive Patch Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Medicated Adhesive Patch Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medicated Adhesive Patch Value Chain Analysis
  2. 9.1.1 Medicated Adhesive Patch Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medicated Adhesive Patch Production Mode & Process
  6. 9.2 Medicated Adhesive Patch Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medicated Adhesive Patch Distributors
  9. 9.2.3 Medicated Adhesive Patch Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst